Cato Research
Leslie DeVos has more than 35 years in the biopharmaceutical/healthcare industry, along with strong expertise in biotech product development.
Prior to joining CATO SMS, DeVos served as the global head of Parexel’s Regulatory and Compliance team for over 13 years, where she played a key role in establishing and leading a team of global health authority experts responsible for the successful development and launch of many new therapies. DeVos’ experience includes biotech, regulatory, and clinical operations, project management/LEAN Six Sigma in the areas of oncology and sepsis, and several orphan indications.
She holds a Bachelor of Science degree in Nursing from The Catholic University of America and a Master of Science in Nursing from the University of Maryland. Prior to her biopharmaceutical career, she served as an oncology clinical specialist and critical care nurse.
This person is not in the org chart
This person is not in any offices
Cato Research
Cato Research has merged with SMS-oncology forming CATO SMS, a fully integrated global company, delivering innovative strategies and robust solutions based on over 30 years of background in regulatory insight, therapeutic experience, and operational expertise.